Please login to the form below

Not currently logged in
Email:
Password:

Latuda

This page shows the latest Latuda news and features for those working in and with pharma, biotech and healthcare.

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

The deal is good news for both parties – Sumitomo needs new products ahead of the loss of its US patent for its star schizophrenia drug Latuda, and it will help Roivant

Latest news

  • EU approval for Takeda’s schizophrenia drug EU approval for Takeda’s schizophrenia drug

    Takeda and development partner Dainippon Sumitomo Pharma have won European approval for their schizophrenia treatment Latuda (lurasidone). ... Smith previously described Latuda as a potential blockbuster in an interview with PMLiVE.

  • GSK's diabetes drug among CHMP recommendations GSK's diabetes drug among CHMP recommendations

    s antipsychotic Latuda and Linepharma France's Hemoprostol for haemorrhage in women. ... 2013. Takeda's antipsychotic and Linepharma's Hemoprostol. Elsewhere in the CHMP opinions, Takeda received a recommendation for the use of Latuda (lurasidone) in the

  • Coronary conundrums

    US. Lurasidone. Latuda (Sunovion Pharmaceuticals). Schizophrenia. US an Puerto Rico. Paracetamol.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics